Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

A pay-for-performance program for diabetes care in Taiwan: a preliminary assessment.

Lee TT, Cheng SH, Chen CC, Lai MS.

Am J Manag Care. 2010 Jan;16(1):65-9.

2.

Tibial artery calcification as a marker of amputation risk in patients with peripheral arterial disease.

Guzman RJ, Brinkley DM, Schumacher PM, Donahue RM, Beavers H, Qin X.

J Am Coll Cardiol. 2008 May 20;51(20):1967-74. doi: 10.1016/j.jacc.2007.12.058.

3.

Cilostazol for peripheral arterial disease.

Robless P, Mikhailidis DP, Stansby GP.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003748. doi: 10.1002/14651858.CD003748.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;10:CD003748.

PMID:
18254032
5.

Peripheral arterial disease in patients with diabetes.

Marso SP, Hiatt WR.

J Am Coll Cardiol. 2006 Mar 7;47(5):921-9. Epub 2006 Feb 9. Review.

6.

Epidemiology and pathophysiology of lower extremity peripheral arterial disease.

Garcia LA.

J Endovasc Ther. 2006 Feb;13 Suppl 2:II3-9. Review.

PMID:
16472007
7.

Medical treatment of peripheral arterial disease.

Hankey GJ, Norman PE, Eikelboom JW.

JAMA. 2006 Feb 1;295(5):547-53. Review.

PMID:
16449620
8.

Coronary stent restenosis in patients treated with cilostazol.

Douglas JS Jr, Holmes DR Jr, Kereiakes DJ, Grines CL, Block E, Ghazzal ZM, Morris DC, Liberman H, Parker K, Jurkovitz C, Murrah N, Foster J, Hyde P, Mancini GB, Weintraub WS; Cilostazol for Restenosis Trial (CREST) Investigators.

Circulation. 2005 Nov 1;112(18):2826-32. Epub 2005 Oct 24.

9.

Cilostazol reduces target lesion revascularization after percutaneous transluminal angioplasty in the femoropopliteal artery.

Iida O, Nanto S, Uematsu M, Morozumi T, Kotani J, Awata M, Onishi T, Ito N, Oshima F, Minamiguchi H, Kitakaze M, Nagata S.

Circ J. 2005 Oct;69(10):1256-9.

10.
11.
12.

Peripheral arterial disease in people with diabetes.

American Diabetes Association.

Diabetes Care. 2003 Dec;26(12):3333-41. Review. No abstract available.

PMID:
14633825
13.

Does universal health insurance make health care unaffordable? Lessons from Taiwan.

Lu JF, Hsiao WC.

Health Aff (Millwood). 2003 May-Jun;22(3):77-88.

15.

Amputations and diabetes: a case-control study.

Trautner C, Haastert B, Giani G, Berger M.

Diabet Med. 2002 Jan;19(1):35-40.

PMID:
11869301
16.

Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome.

Jude EB, Oyibo SO, Chalmers N, Boulton AJ.

Diabetes Care. 2001 Aug;24(8):1433-7.

PMID:
11473082
17.

Medical management of peripheral arterial disease.

Creager MA.

Cardiol Rev. 2001 Jul-Aug;9(4):238-45. Review.

PMID:
11405904
18.

Medical treatment of peripheral arterial disease and claudication.

Hiatt WR.

N Engl J Med. 2001 May 24;344(21):1608-21. Review. No abstract available.

PMID:
11372014
19.

Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery.

Kohda N, Tani T, Nakayama S, Adachi T, Marukawa K, Ito R, Ishida K, Matsumoto Y, Kimura Y.

Thromb Res. 1999 Nov 15;96(4):261-8.

PMID:
10593428
20.

Epidemiology and significance of atrial fibrillation.

Ryder KM, Benjamin EJ.

Am J Cardiol. 1999 Nov 4;84(9A):131R-138R. Review.

PMID:
10568672

Supplemental Content

Support Center